Stock analysis, price data, and AI-powered insights for Cardinal Health (CAH).
Cardinal Health operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for CAH.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). CAH Stock Intelligence Report. [stoxpulse.com/stocks/cah]
Disclaimer: The information on this page about Cardinal Health (CAH) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Cardinal Health.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 6%
Jun 30
Scherer sold 100 shares
Aug 19
Scherer sold 2K shares
Aug 19
2 Cash-Producing Stocks Worth Your Attention and 1...
16h ago
AbbVie vs. CRISPR Therapeutics: Which Healthcare S...
19h ago
StoxPulse AI results for CAH: Pulse Score 57/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a bullish outlook.
Market Cap
$54.63B
P/E Ratio
25.9
EPS
$1.97
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Sep 25
+15.9%
Dec 25
+9.4%
Mar 26
+12.6%
Jun 26
+6.4%
Beat estimates 4 of 4 quarters (100%)
Sector
Healthcare
Industry
Health Care Distributors
2 Cash-Producing Stocks Worth Your Attention and 1 We Ignore
AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
McKesson Raises Outlook, Eyes Oncology Growth With Precision Medicine Deal
Cardinal Health, Inc. (CAH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?